Tibet Duo Rui Pharmaceutical Co., Ltd. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CNY 333.67 million compared to CNY 400.98 million a year ago. Revenue was CNY 334.3 million compared to CNY 401.05 million a year ago.

Net income was CNY 18.85 million compared to CNY 20.5 million a year ago. Basic earnings per share from continuing operations was CNY 0.24 compared to CNY 0.26 a year ago. Diluted earnings per share from continuing operations was CNY 0.24 compared to CNY 0.26 a year ago.